Mon.May 06, 2024

article thumbnail

STAT+: NYU professors who defended vaping didn’t disclose ties to Juul, documents show

STAT

WASHINGTON – Two New York University professors collaborated directly with executives of the vaping company Juul without disclosing those relationships to academic journals or Congress, a STAT investigation reveals. At the height of the youth vaping crisis, when many public health experts were calling for sweeping action that could upend the entire industry, David Abrams and Ray Niaura emerged as two authoritative voices willing to defend vaping — despite its growing popularity amo

article thumbnail

As drug shortages reach record highs, regulators float next steps

PharmaVoice

With many chemo and ADHD drugs stuck in stubborn shortages, several agencies are looking for new solutions to boost supplies.

299
299
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

STAT+: Alzheimer’s risk gene APOE4 may cause a distinct form of the disease, study suggests

STAT

For more than 30 years, Alzheimer’s researchers have thought of APOE4 as a major genetic risk factor for most cases of the devastating neurologic disease. But a new study published on Monday argues that this gene variant plays an even more important role than scientists had realized and causes a distinct form of Alzheimer’s. Researchers analyzed data from more than 13,000 people, including nearly 800 APOE4 homozygotes, people who carry two copies of the gene variant.

359
359
article thumbnail

Hot off the press: Bridge to EM curriculum (2nd edition) released

ALiEM - Pharm Pearls

It has been 3 years since the 8-week, self-guided Bridge to Emergency Medicine (EM) curriculum was launched to help graduating medical students prepare for EM residency. The curriculum has been viewed over 43,000 times and we have awarded over 5,000 ALiEMU course certificates. It is now a part of many residency programs’ intern boot camp. Launching the 2nd edition of Bridge to EM (2024) We are thrilled to announce that we launching the second edition of the curriculum.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Meet the scientist sending tumors into space

STAT

What happens when you catapult cancer into space? Or shoot stem cells toward the stars? Catriona Jamieson, a hematologist and director of the Sanford Stem Cell Institute at the University of California, San Diego, has done both. Through collaborations with organizations like NASA, her lab has sent tumors and stem cells aboard private spaceflights like SpaceX CRS-24 and the recent Axiom-3 mission to be studied in the International Space Station.

335
335
article thumbnail

FDA’s new diagnostic rules draw pharma criticism

PharmaVoice

Tests frequently used in clinical trials will soon be regulated like medical devices — with some exceptions.

237
237

More Trending

article thumbnail

The Promise of RFID for Improving Medication Inventory Management

Pharmaceutical Commerce

Radio frequency identification (RFID) not only helps hospitals boost their medication safety standards, as it also allows clinicians to continue to provide quality patient care.

Hospitals 111
article thumbnail

Opinion: The world is relying on the United States to get value-based drug pricing right

STAT

The changing landscape of drug pricing policy in the U.S. has implications for the global pace and direction of innovation. Drug policy changes are being influenced by perceptions of the value of novel medicines relative to their budgetary impacts, with some believing that many medicines may not be worth their cost, creating an important role for health technology assessments (HTA).

article thumbnail

“Landmark” genetic blindness CRISPR trial outcomes released

European Pharmaceutical Review

New results from a Phase I/II clinical trial of a CRISPR/Cas9 gene editing therapy show that around 79 percent of patients with a rare form of inherited blindness experienced “measurable improvement”. The BRILLIANCE trial included 14 participants (12 adults and two children) who received an injection of EDIT-101 in one eye. These individuals had a form of Leber Congenital Amaurosis (LCA) caused by mutations in the centrosomal protein 290 (CEP290) gene.

Hospitals 105
article thumbnail

High blood pressure in kids doubles their risk of cardiovascular disease, study finds, bringing a call for routine screening

STAT

Children and adolescents diagnosed with high blood pressure have double the risk of major cardiovascular problems as adults, a new study that followed them into their 20s and 30s reports.  It’s another example of a serious disease striking people at younger ages than in previous generations and should serve as a call to action for routine blood pressure screening in primary care, Rahul Chanchlani, the senior author of the new study, told STAT.

295
295
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Bluebird preps for first commercial use of sickle cell gene therapy

BioPharma Dive

A 12-year-old boy in the Washington, D.C., area is set become the first patient treated with Lyfgenia since its U.S. approval last December.

120
120
article thumbnail

STAT+: UnitedHealth CEO downplays his company’s control over physicians

STAT

You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money in medicine. Sign up to get it in your inbox every Monday. About that 90,000 number UnitedHealth Group CEO Andrew Witty faced Congress last week, where lawmakers pressed him on the Change Healthcare cyberattack (my colleague Brittany Trang  watched the hearings closely  and tried to break down  what it all means ).

Hospitals 262
article thumbnail

Can a Device Be Found Not Substantially Equivalent Because of Cybersecurity Risks? A Review of FDA’s Draft Guidance on Cybersecurity in Medical Devices

FDA Law Blog: Biosimilars

By Lisa M. Baumhardt, Senior Medical Device Regulation Expert & Adrienne R. Lenz, Principal Medical Device Regulation Expert — FDA recently issued a draft guidance which would update the agency’s Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions guidance. The draft guidance provides recommendations on what is required to meet cybersecurity obligations under section 524B of the Food, Drug and Cosmetic Act (FD&C).

article thumbnail

STAT+: Steward files for bankruptcy, leaving its eight Massachusetts hospitals in limbo

STAT

Steward Health Care, which once trumpeted its community hospital system as a low-cost alternative to Boston’s medical goliaths before expanding nationally and falling into a deep financial crisis, filed for bankruptcy protection early Monday morning. Under Chapter 11 of the US bankruptcy code, Steward will become a “debtor in possession,” continuing to operate its 32 hospitals in eight states while it seeks to restructure its debt under court supervision.

Hospitals 243
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Alternative methods for mycobacterial testing in biological products

European Pharmaceutical Review

Following a review on the suitability of different technologies, researchers have determined that “[nucleic acid amplification techniques] NATs combined with an efficient extraction method” is the fitting alternative for compendial mycobacterial testing in biological products. The current challenge in mycobacterial testing information on using mycobacterial testing for the quality control of biologicals is limited, the paper noted.

98
article thumbnail

Merck may have a competition for ever-scarce BCG

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning! Today, we learn more about studying tumors at the International Space Station, study the buzzy Amgen weight loss drug MariTide, and find a lawsuit in which a former Spark Therapeutics executive is accusing ex-colleagues of sexism.

article thumbnail

Sharp spike in pharma, healthcare funding in April 2024, touches $332 mn

Express Pharma

API Holdings secured the biggest deal ($216 million), followed by La Renon ( $70 million) and Biodeal Pharmaceuticals ($13.2 million). Funding was raised by 291 per cent for the sector in April 2024, 1045 per cent higher than the same month last year ($29 million) , accounting for $332 million, over 15 rounds in total. As per the data presented by Tracxn.com, API Holdings secured the biggest deal by raising $216 million in healthcare, healthtech and life sciences.

102
102
article thumbnail

At Milken Institute conference, CDC director Mandy Cohen talks public health preparedness

STAT

In the spring of 2020, as Covid-19 took hold around the world, Centers of Disease Control and Prevention director Mandy Cohen was the head of North Carolina’s Department of Health and Human Services. Among the challenges she and her team had to face was the antiquated state of data pervasive in public health and medicine. “One of our first things that we had to do was stop receiving lab data by fax machine ,” Cohen shared at the Milken Institute 2024 Global Conference , wher

205
205
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Top charities team up with $300m for climate, health equity

pharmaphorum

The Novo Nordisk Foundation, the Bill & Melinda Gates Foundation, and Wellcome have joined forces to tackle some of the most pressing threats to human health and wellbeing. The new initiative gets underway with $300 million in funding over three years earmarked for handling infectious diseases and antimicrobial resistance (AMR), addressing climate change, and raising our understanding of how nutrition can impact immunity, disease, and the development of children.

article thumbnail

APAC leads in asthma clinical trials between 2019-2023: GlobalData

Express Pharma

China, India, and South Korea among the top three countries The Asia-Pacific (APAC) region is leading in clinical trials in Asthma, with China, India, and South Korea among the top countries in this space, according to GlobalData. According to GlobalData’s Clinical Trials Database, during 2019-23, 51.8 per cent of asthma trials were initiated in the APAC region.

94
article thumbnail

Boehringer raises hope of diabetic macular ischaemia therapy

pharmaphorum

Boehringer drug shows promise in diabetic macular ischaemia (DMI), a common and irreversible complication of the eye in people with diabetes with no approved therapies

Diabetes 103
article thumbnail

PHARMAP 2024 held in Amsterdam, marks its fourth edition

Express Pharma

The event brought together over 330 professionals from across the industry’s value chain Pharmaceutical Manufacturing and Packaging Congress (PHARMAP 2024) was held in Amsterdam, Netherlands on April 22-23, 2024. According to its statement, PHARMAP 2024 brought together over 330 professionals from across the industry’s value chain. Among the attendees, contract manufacturing organisations, service providers and experts were present.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Citi analyst Andrew Baum to head Pfizer strategy team

pharmaphorum

Pfizer has named Citi analyst Andrew Baum as its chief strategy and innovation officer, taking point on portfolio management and capital deployment

101
101
article thumbnail

Research led by Sydney University develop nanotech-based oral insulin medicine

Express Pharma

The new nano carrier could help people with diabetes avoid side-effects linked to insulin injections such as hypoglycemia, inform the researchers Research led by the University of Sydney and Sydney Local Health District has developed a system using nanotechnology that could allow people with diabetes to take oral insulin in the future. Offering 75 million people worldwide, who use insulin for diabetes, a more effective and needle-free alternative.

article thumbnail

Activist investor urges changes to Novavax board

pharmaphorum

Shah Capital has stepped up its campaign for change at vaccine producer Novavax, lobbying against the re-election of three directors and executive pay packages in a letter to fellow stockholders. The hedge fund says it wants to send a “strong and clear message” to the board at Novavax, reiterating the claim – first made a few weeks ago – that the company is “being hindered by an overly conservative board and management that clings to failed strategies.

article thumbnail

As drug shortages reach record highs, regulators weigh next steps

BioPharma Dive

With many chemotherapy and ADHD drugs stuck in stubbornly short supply, several agencies are looking for new solutions.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

UK MHRA approves ViiV Healthcare’s cabotegravir formulations for HIV-1

Pharmaceutical Technology

The UK MHRA approved two formulations of ViiV Healthcare’s cabotegravir, offering a new prevention option for HIV-1 infection.

83
article thumbnail

Chinese companies lead ADC development pipeline: GlobalData

Express Pharma

A significant level of increase is seen in Chinese companies within the Antibody-drug conjugates market. According to GlobalData, a significant level of increase is seen in Chinese companies within the Antibody-drug conjugates market. Half of the top 10 developers seek to capitalise on potential returns. ADCs combine the specificity of monoclonal antibodies with the potency of cytotoxic drugs, via a linker, to selectively target and eliminate cancerous cells.

article thumbnail

Gossamer sells rights to drug it hopes can rival a new Merck therapy

BioPharma Dive

One analyst thinks the collaboration “bodes well” for Gossamer, which has had trouble convincing investors its drug seralutinib can compete on the market.

67
article thumbnail

Participants of pioneering CRISPR gene editing trial see vision improve

World Pharma News

About 79% of clinical trial participants experienced measurable improvement after receiving experimental, CRISPR-based gene editing that is designed to fix a rare form of blindness, according to a paper published today in the New England Journal of Medicine. "This trial shows CRISPR gene editing has exciting potential to treat inherited retinal degeneration," said Mark Pennesi, M.D., Ph.D., a corresponding author on the paper, an ophthalmologist and Oregon Health & Science University's lead

76
article thumbnail

AstraZeneca ups stake in Cellectis in latest cell therapy bet

BioPharma Dive

The British drugmaker, which has made genetic medicine a larger priority of late, added $140 million to a deal to develop up to 10 gene and cell therapies.

70